The Life Science industry has been in the grasps of a reproducibility emergency for various years.
Abcam is driving the way in tending to this with our scope of recombinant monoclonal antibodies and knockout altered cell lines for highest quality level approval.
Kindly check that this item addresses your issues prior to buying.The NS1 protein is a significant non-strucutural protein communicated by t he Zika Virus. The NS1 monomer is a glycosylated protein of around 45kD, which partners with lipids and structures a homodimer inside contaminated cells.
It is essential for viral replication, and is additionally emitted into the extracellular space as a hexameric lipoprotein molecule, which is associated with invulnerable avoidance and pathogenesis by collaborating with parts from both the inborn and versatile resistant frameworks, as well as other host factors. NS1 is one of the major antigenic markers for viral contamination with Zika.
Zika infection is an arising sickness that is spread by Aedes mosquitoes. The infection was first detached in Central Africa, and has since spread to South Asia and all the more as of late to South America.
It is an individual from the flavivirus family, and is fundamentally firmly connected with infections like Dengue Fever Virus.Episodes were accounted for in Micronesia in 2007 and in Brazil in 2015, affirming somewhere around 13 autochthonous diseases. The Zika infection episode in Brazil in 2016 has acquired overall consideration, and has been connected to a rising number of microcephaly cases.
In April 2016 the Centers for Disease Control, in the USA, affirmed the connection between Zika infection contamination of the baby with microcephaly.
Clinically Zika infection can cause gentle fever, rash, myalgia, arthralgia and cerebral pains, with one of every four tainted people being asymptomatic. Because of comparative side effects Zika infection tainted people can undoubtedly be mis-analyzed as a dengue disease as well as the other way around.
What’s more, Zika infection has been embroiled in causing microcephaly through transmission in utero. There is no antibody or explicit treatment accessible for Zika infection.
Zika infection (ZIKV) is a RNA infection of the Flaviviridae family, and is basically near dengue and chikungunya infections. ZIKV can be sent by Aedes mosquitoes and sexual contact. The relationship of ZIKV contamination with microcephaly and neurological sicknesses has as of late featured a worldwide arising general wellbeing concern.
ZIKV NS1 (Non-Structural protein 1) is a glycoprotein that fills in as a significant host-cooperation particle that capacities in flaviviral replication, pathogenesis and invulnerable avoidance 1. The as of late tackled design of ZIKV NS1 has shown it has one of a kind surface attributes that can be taken advantage of in the advancement of novel analytic instruments for Zika contamination.
B7160 was created against recombinant Zika NS1 protein communicated from bug cells and cleaned from hybridoma cell culture by means of protein A partiality chromatography.
The huge T antigen (TAg) of Simian infection 40 goes about as an initiator of DNA replication, partakes in cell change, and incites cell development. Various utilitarian areas have been described including the N-terminal J space, atomic confinement signal (NLS), inside helicase area, Rb and topoisomerase I collaborating space, p53 and ATP restricting space.
The p53-collaborating space is additionally fundamental for restricting p300/CBP. Phosphorylation of TAg by a few kinases might control its capacity both decidedly and adversely.
The viral replication of simian infection 40 (SV40) is done by a solitary protein, T-antigen. This element makes the infection a helpful framework for figuring out the course of replication and to recognize the parts of replication apparatus.
It capacities as a DNA helicase alongside a cell single-strand DNA restricting protein and topoisomerase I or II, prompting broad beginning loosening up and development of a pre-commencement complex. The T-antigen partners with two growth silencer proteins, p53 and the retinoblastoma protein pRb, and inactivates them.
The enormous T antigen (TAg) of Simian infection 40 goes about as an initiator of DNA replication, takes an interest in cell change, and incites cell development. Various useful spaces have been described including the N-terminal J area, atomic restriction signal (NLS), inner helicase space, Rb and topoisomerase I collaborating area, p53 and ATP restricting space.
The p53-collaborating space is likewise fundamental for restricting p300/CBP. Phosphorylation of TAg by a few kinases might manage its capacity both decidedly and adversely.
The viral replication of simian infection 40 (SV40) is done by a solitary protein, T-antigen. This element makes the infection a valuable framework for grasping the course of replication and to distinguish the parts of replication apparatus.
Zika Virus NS1 Recombinant | ||||
| MBS319788-1mg | MyBiosource | 1mg | 1275 EUR | |
Zika Virus NS1 Recombinant | ||||
| MBS319788-5x1mg | MyBiosource | 5x1mg | 5490 EUR | |
OPMA04849-1MG - Recombinant Zika Virus NS1 Protein | ||||
| OPMA04849-1MG | Aviva Systems Biology | 1mg | 1399 EUR | |
Zika Virus NS1 Recombinant Protein | ||||
| 97-074 | ProSci | 0.05 mg | 752.1 EUR | |
Recombinant Zika Virus NS1 protein | ||||
| DAGA-038 | Creative Diagnostics | 1 mg | 1714.8 EUR | |
Recombinant Zika Virus NS1 protein | ||||
| DAGA-046 | Creative Diagnostics | 100 µg | 774 EUR | |
Recombinant Zika virus NS1 Protein | ||||
| P1064-10 | Biovision | each | 189.6 EUR | |
Recombinant Zika virus NS1 Protein | ||||
| P1064-50 | Biovision | each | 366 EUR | |
Zika virus NS1/Env. recombinant antigen | ||||
| 8827 | Virostat | 100 ug | 673.36 EUR | |
Recombinant Zika Virus NS1 Protein (Biotin) | ||||
| VAng-Lsx0576-inquire | Creative Biolabs | inquire | Ask for price | |
Recombinant Zika Virus NS1 Protein (HEK293) [His] | ||||
| DAGA-047 | Creative Diagnostics | 100 ug | 974.4 EUR | |
Recombinant Zika Virus NS1 Protein (Insect cells) | ||||
| VAng-Lsx0577-100g | Creative Biolabs | 100 µg | 1365.6 EUR | |
Human Zika Virus NS1 Recombinant Protein His Tag Lyophilized | ||||
| IHUZIKANS1RHISLY50UG | Innovative research | each | 899 EUR | |
Human Zika Virus NS1 Recombinant Protein His Tag Lyophilized | ||||
| MBS8433790-INQUIRE | MyBiosource | INQUIRE | Ask for price | |
Zika Virus ENV-NS1 recombinant protein | ||||
| MBS485200-01mg | MyBiosource | 0.1mg | 300 EUR | |
Zika Virus ENV-NS1 recombinant protein | ||||
| MBS485200-1mg | MyBiosource | 1mg | 1300 EUR | |
Zika Virus ENV-NS1 recombinant protein | ||||
| MBS485200-5x1mg | MyBiosource | 5x1mg | 5795 EUR | |
Recombinant Zika Virus NS1 Protein (aa 805-1147) (E. coli) | ||||
| VAng-Lsx0578-100g | Creative Biolabs | 100 µg | 712.8 EUR | |
Recombinant Zika Virus NS1 Protein (aa 805-1147) (293 cells) | ||||
| VAng-Lsx0579-100g | Creative Biolabs | 100 µg | 1210.8 EUR | |
OPNB00063-1MG - Zika Virus -NS1 (Suriname strain) | ||||
| OPNB00063-1MG | Aviva Systems Biology | 1mg | 4119 EUR | |
Zika Virus NS1 Protein | ||||
| abx061380-1mg | Abbexa | 1 mg | 1722 EUR | |
Zika Virus NS1 antigen | ||||
| 00346-V-01mg | Virogen | 0,1 mg | 321 EUR | |
Zika Virus NS1 antigen | ||||
| 00346-V-1000ug | Virogen | 1000 ug | 1539 EUR | |
Zika virus NS1 protein | ||||
| 30-1931 | Fitzgerald | 100 ug | 3450 EUR | |
Zika virus NS1 protein | ||||
| 30-1936 | Fitzgerald | 100 ug | 1700 EUR | |
Zika virus NS1 Protein | ||||
| E40VAG345 | EnoGene | 20ug | 495 EUR | |
Zika Virus NS1 Protein | ||||
| abx061380-100g | Abbexa | 100 µg | Ask for price | |
Zika Virus NS1 Protein | ||||
| abx061380-10g | Abbexa | 10 µg | 1725 EUR | |
Zika Virus NS1 Protein | ||||
| abx061380-50g | Abbexa | 50 µg | Ask for price | |
Zika virus NS1 protein | ||||
| MBS5304722-01mg | MyBiosource | 0.1mg | 395 EUR | |
Zika virus NS1 protein | ||||
| MBS5304722-1mg | MyBiosource | 1(mg) | 2560 EUR | |
Zika virus NS1 protein | ||||
| MBS5304722-5x1mg | MyBiosource | 5x1mg | 11305 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024134-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024135-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024136-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024137-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024138-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024139-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024140-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024141-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024142-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024143-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024144-1mg | Abbexa | 1 mg | 1730.4 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024159-1mg | Abbexa | 1 mg | 727.2 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024160-1mg | Abbexa | 1 mg | 1212 EUR | |
Zika virus NS1 antibody | ||||
| 10-2707 | Fitzgerald | 1 mg | 295 EUR | |
Zika virus NS1 antibody | ||||
| 10-2708 | Fitzgerald | 1 mg | 295 EUR | |
Zika virus NS1 antibody | ||||
| 10-2709 | Fitzgerald | 1 mg | 295 EUR | |
Zika virus NS1 antibody | ||||
| 10-2710 | Fitzgerald | 1 mg | 295 EUR | |
Zika virus NS1 antibody | ||||
| 10-2711 | Fitzgerald | 1 mg | 278 EUR | |
Zika virus NS1 antibody | ||||
| 70-1086 | Fitzgerald | 500ug | Ask for price | |
Zika virus NS1 antibody | ||||
| 70-1087 | Fitzgerald | 500 ug | Ask for price | |
Zika Virus NS1 Antibody | ||||
| abx024134-400l | Abbexa | 400 µl | Ask for price | |
Zika Virus NS1 Antibody | ||||
| abx024134-80l | Abbexa | 80 µl | 1550 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024135-200l | Abbexa | 200 µl | Ask for price | |
Zika Virus NS1 Antibody | ||||
| abx024135-50l | Abbexa | 50 µl | 1550 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024136-400l | Abbexa | 400 µl | Ask for price | |
Zika Virus NS1 Antibody | ||||
| abx024136-80l | Abbexa | 80 µl | 1550 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024137-400l | Abbexa | 400 µl | Ask for price | |
Zika Virus NS1 Antibody | ||||
| abx024137-80l | Abbexa | 80 µl | 1550 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024138-400l | Abbexa | 400 µl | Ask for price | |
Zika Virus NS1 Antibody | ||||
| abx024138-80l | Abbexa | 80 µl | 1550 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024139-400l | Abbexa | 400 µl | Ask for price | |
Zika Virus NS1 Antibody | ||||
| abx024139-80l | Abbexa | 80 µl | 1550 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024140-400l | Abbexa | 400 µl | Ask for price | |
Zika Virus NS1 Antibody | ||||
| abx024140-80l | Abbexa | 80 µl | 1550 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024141-400l | Abbexa | 400 µl | Ask for price | |
Zika Virus NS1 Antibody | ||||
| abx024141-80l | Abbexa | 80 µl | 1212.5 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024142-400l | Abbexa | 400 µl | Ask for price | |
Zika Virus NS1 Antibody | ||||
| abx024142-80l | Abbexa | 80 µl | 1250 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024143-400l | Abbexa | 400 µl | Ask for price | |
Zika Virus NS1 Antibody | ||||
| abx024143-80l | Abbexa | 80 µl | 1250 EUR | |
Zika Virus NS1 Antibody | ||||
| abx024144-400l | Abbexa | 400 µl | Ask for price | |
Zika Virus NS1 Antibody | ||||
| abx024144-80l | Abbexa | 80 µl | 1250 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304710-05mg | MyBiosource | 0.5mg | 740 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304710-1mg | MyBiosource | 1(mg) | 1310 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304710-5x1mg | MyBiosource | 5x1mg | 5735 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304711-05mg | MyBiosource | 0.5mg | 740 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304711-1mg | MyBiosource | 1(mg) | 1155 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304711-5x1mg | MyBiosource | 5x1mg | 5040 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304712-05mg | MyBiosource | 0.5mg | 740 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304712-1mg | MyBiosource | 1(mg) | 1155 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304712-5x1mg | MyBiosource | 5x1mg | 5040 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304713-05mg | MyBiosource | 0.5mg | 750 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304713-1mg | MyBiosource | 1(mg) | 1155 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304713-5x1mg | MyBiosource | 5x1mg | 5040 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304714-05mg | MyBiosource | 0.5mg | 690 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304714-1mg | MyBiosource | 1(mg) | 1310 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304714-5x1mg | MyBiosource | 5x1mg | 5735 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304724-05mg | MyBiosource | 0.5mg | 695 EUR | |
Zika virus NS1 antibody | ||||
| MBS5304724-5x05mg | MyBiosource | 5x0.5mg | 2975 EUR | |
Zika Virus NS1 Antibody | ||||
| MBS5400852-01mg | MyBiosource | 0.1mg | 445 EUR | |
It capacities as a DNA helicase alongside a cell single-strand DNA restricting protein and topoisomerase I or II, prompting broad beginning loosening up and arrangement of a pre-inception complex. The T-antigen partners with two cancer silencer proteins, p53 and the retinoblastoma protein pRb, and inactivates them.